Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gulati

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Haematology and Blood Transfusion|January 1, 1989
Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulationJ Atzpodien, C Bührer, S C Gulati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
Autologous bone marrow transplantation for patients with poor-prognosis lymphomaS C Gulati, B Shank, P Black, et al.
Acta Haematologica|January 1, 1988
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrowS C Gulati, J Atzpodien, A Langleben, et al.
Blood|March 1, 1985
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrowS Siena, H Castro-Malaspina, S C Gulati, et al.
Cancer|January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedR J Motzer, S C Gulati, J P Crown, et al.
Cancer Research|August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsR J Motzer, S C Gulati, W P Tong, et al.
Progress in Clinical and Biological Research|January 1, 1990
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamideC Shimazaki, T Inaba, S Murakami, et al.
Cancer Research|June 1, 1985
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysisT T Chang, S C Gulati, T C Chou, et al.
Stem Cells (Dayton, Ohio)|July 1, 1995
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trialsC L Bennett, S L George, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's diseaseJ Yahalom, S C Gulati, M Toia, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Haematology and Blood Transfusion|January 1, 1989
Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulationJ Atzpodien, C Bührer, S C Gulati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
Autologous bone marrow transplantation for patients with poor-prognosis lymphomaS C Gulati, B Shank, P Black, et al.
Acta Haematologica|January 1, 1988
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrowS C Gulati, J Atzpodien, A Langleben, et al.
Blood|March 1, 1985
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrowS Siena, H Castro-Malaspina, S C Gulati, et al.
Cancer|January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedR J Motzer, S C Gulati, J P Crown, et al.
Cancer Research|August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsR J Motzer, S C Gulati, W P Tong, et al.
Progress in Clinical and Biological Research|January 1, 1990
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamideC Shimazaki, T Inaba, S Murakami, et al.
Cancer Research|June 1, 1985
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysisT T Chang, S C Gulati, T C Chou, et al.
Stem Cells (Dayton, Ohio)|July 1, 1995
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trialsC L Bennett, S L George, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's diseaseJ Yahalom, S C Gulati, M Toia, et al.
Pageof 12